{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:46:12Z","timestamp":1789076772163,"version":"build-2803163510"},"reference-count":15,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.4158\/ep15950.or","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T15:37:00Z","timestamp":1447774620000},"page":"383-388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Metabolic Effects Of Hormone Therapy In Transgender Patients"],"prefix":"10.1016","volume":"22","author":[{"given":"JohnDavid.","family":"Fernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LisaR.","family":"Tannock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP15950.OR_bb0010","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association. Gender dysphoria","year":"2013"},{"key":"10.4158\/EP15950.OR_bb0015","series-title":"How many people are lesbian, gay, bisexual, and transgender?","first-page":"1","author":"Gates","year":"2011"},{"key":"10.4158\/EP15950.OR_bb0020","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15950.OR_bb0025","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/01.med.0000436188.95351.4d","article-title":"Progress on the road to better medical care for transgender patients","volume":"20","author":"Gardner","year":"2013","journal-title":"Current Opinion in Endocrinology, Curr Opin Endocrinol Diabetes Obes"},{"key":"10.4158\/EP15950.OR_bb0030","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1210\/jc.2014-3301","article-title":"Effects of low-dose versus placebo or conventional-dose postmenopausal hormone therapy on variables related to cardiovascular risk: a systematic review and meta-analyses of randomized clinical trials","volume":"100","author":"Casanova","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15950.OR_bb0035","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.amjmed.2013.10.009","article-title":"Interpreting laboratory results in transgender patients on hormone therapy","volume":"127","author":"Roberts","year":"2014","journal-title":"Am J Med"},{"key":"10.4158\/EP15950.OR_bb0040","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF01542220","article-title":"Physical and hormonal evaluation of transsexual patients: a longitudinal study","volume":"15","author":"Meyer","year":"1986","journal-title":"Arch Sex Behav"},{"key":"10.4158\/EP15950.OR_bb0045","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/0004563215587763","article-title":"A review of the physical and metabolic effects of cross-sex hormonal therapy in the treatment of gender dysphoria","volume":"53","author":"Seal","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"10.4158\/EP15950.OR_bb0050","doi-asserted-by":"crossref","first-page":"2230","DOI":"10.1210\/jc.2007-2467","article-title":"Effect of long-term administration of cross-sex hormone therapy on serum and urinary uric acid in transsexual persons","volume":"93","author":"Yahyaoui","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP15950.OR_bb0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.steroids.2014.05.004","article-title":"Outcomes of testosterone therapy in men with testosterone deficiency (TD): Part II","volume":"88","author":"Traish","year":"2014","journal-title":"Steroids"},{"key":"10.4158\/EP15950.OR_bb0060","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1111\/j.1743-6109.2012.02876.x","article-title":"Long-term evaluation of cross-sex hormone treatment in transsexual persons","volume":"9","author":"Wierckx","year":"2012","journal-title":"J Sex Med"},{"key":"10.4158\/EP15950.OR_bb0065","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1530\/EJE-09-0412","article-title":"Safety aspects of 36 months of administration of long-acting intramuscular testosterone undecanoate for treatment of female-to-male transgender individuals","volume":"161","author":"Jacobeit","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.4158\/EP15950.OR_bb0070","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1111\/j.1743-6109.2010.01962.x","article-title":"Safety of physiological testosterone therapy in women: lessons from female-to-male transsexuals (FMT) treated with pharmacological testosterone therapy","volume":"7","author":"Traish","year":"2010","journal-title":"J Sex Med"},{"key":"10.4158\/EP15950.OR_bb0075","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1111\/jsm.12698","article-title":"Effects of three different testosterone formulations in female-to-male transsexual persons","volume":"11","author":"Pelusi","year":"2014","journal-title":"J Sex Med"},{"key":"10.4158\/EP15950.OR_bb0080","first-page":"55","article-title":"Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals","volume":"2","author":"Weinand","year":"2015","journal-title":"J Clin Transl Endocrinol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20393253?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20393253?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:01:10Z","timestamp":1761516070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20393253"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1530891X20393253"],"URL":"https:\/\/doi.org\/10.4158\/ep15950.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic Effects Of Hormone Therapy In Transgender Patients","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP15950.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}